Efficacy in Biologic Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderate-Severe Ulcerative Colitis: UNIFI

Mapping Intimacies ◽

10.1055/s-0039-1691869 ◽

2019 ◽

Author(s):

BE Sands ◽

L Peyrin-Biroulet ◽

C Marano ◽

CD O'Brien ◽

H Zhang ◽

...

Keyword(s):

Ulcerative Colitis ◽

Phase 3 ◽

Severe Ulcerative Colitis

Download Full-text

Sa1887 – General Health Status in Patients with Moderate to Severe Ulcerative Colitis Receiving Ustekinumab: Results from the Phase 3 Unifi Induction and Maintenance Studies

Gastroenterology ◽

10.1016/s0016-5085(19)37953-3 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-442

Author(s):

Silvio Danese ◽

Bruce E. Sands ◽

Rupert W. Leong ◽

Hongyan Zhang ◽

Jewel Johanns ◽

...

Keyword(s):

Ulcerative Colitis ◽

Health Status ◽

General Health ◽

General Health Status ◽

Phase 3 ◽

Severe Ulcerative Colitis

Download Full-text

748 Ustekinumab Improved Work Productivity in Patients With Moderate to Severe Ulcerative Colitis: Results From the Phase 3 UNIFI Induction and Maintenance Studies

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000592528.88422.70 ◽

2019 ◽

Vol 114 (1) ◽

pp. S438-S438

Author(s):

Chenglong Han ◽

Dominik Naessens ◽

Hongyan Zhang ◽

Jewel Johanns ◽

Colleen Marano ◽

...

Keyword(s):

Ulcerative Colitis ◽

Work Productivity ◽

Phase 3 ◽

Severe Ulcerative Colitis

Download Full-text

646 Molecular Response to Ustekinumab in Moderate-to-Severe Ulcerative Colitis by Serum Protein and Colon Transcriptomic Analysis: Results From the UNIFI Phase 3 Maintenance Study

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000592120.98792.10 ◽

2019 ◽

Vol 114 (1) ◽

pp. S378-S378

Author(s):

Katherine Li ◽

Feifei Yang ◽

Karen Hayden ◽

David Strawn ◽

Eric Wadman ◽

...

Keyword(s):

Ulcerative Colitis ◽

Serum Protein ◽

Transcriptomic Analysis ◽

Molecular Response ◽

Phase 3 ◽

Severe Ulcerative Colitis ◽

Maintenance Study

Download Full-text

P406 General health status in patients with moderate to severe ulcerative colitis receiving ustekinumab: results from the Phase 3 UNIFI induction and maintenance studies

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjy222.530 ◽

2019 ◽

Vol 13 (Supplement_1) ◽

pp. S311-S312

Author(s):

S Danese ◽

B E Sands ◽

R W Leong ◽

H Zhang ◽

J Johanns ◽

...

Keyword(s):

Ulcerative Colitis ◽

Health Status ◽

General Health ◽

General Health Status ◽

Phase 3 ◽

Severe Ulcerative Colitis

Download Full-text

Sustained Remission in Patients with Moderate to Severe Ulcerative Colitis: Results from the Phase 3 UNIFI Maintenance Study

10.1055/s-0039-1691865 ◽

2019 ◽

Author(s):

G van Assche ◽

SR Targan ◽

T Baker ◽

CD O'Brien ◽

H Zhang ◽

...

Keyword(s):

Ulcerative Colitis ◽

Sustained Remission ◽

Phase 3 ◽

Severe Ulcerative Colitis ◽

Maintenance Study

Download Full-text

Sa1888 – Ustekinumab Therapy Induced Clinically Meaningful Improvement and Remission As Measured by the Inflammatory Bowel Disease Questionnaire in Patients with Moderate to Severe Ulcerative Colitis: Results from the Phase 3 Unifi Induction and Maintenance Studies

Gastroenterology ◽

10.1016/s0016-5085(19)37954-5 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-442-S-443

Author(s):

Bruce E. Sands ◽

Chenglong Han ◽

Hongyan Zhang ◽

Jewel Johanns ◽

Philippe Szapary ◽

...

Keyword(s):

Ulcerative Colitis ◽

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Phase 3 ◽

Meaningful Improvement ◽

Inflammatory Bowel Disease Questionnaire ◽

Severe Ulcerative Colitis ◽

Inflammatory Bowel ◽

Disease Questionnaire

Download Full-text

Tu1736 – Molecular Response to Ustekinumab in Moderate-To-Severe Ulcerative Colitis by Serum Protein and Biopsy Gene Expression Analysis: Results from the Unifi Phase 3 Induction Study

Gastroenterology ◽

10.1016/s0016-5085(19)39722-7 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-1104-S-1105

Author(s):

Katherine Li ◽

Feifei Yang ◽

Karen Hayden ◽

David Strawn ◽

Eric Wadman ◽

...

Keyword(s):

Gene Expression ◽

Ulcerative Colitis ◽

Serum Protein ◽

Expression Analysis ◽

Gene Expression Analysis ◽

Molecular Response ◽

Phase 3 ◽

Severe Ulcerative Colitis ◽

Induction Study

Download Full-text

OP13 Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI Phase 3 induction study

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjy222.012 ◽

2019 ◽

Vol 13 (Supplement_1) ◽

pp. S008-S009

Author(s):

K Li ◽

F Yang ◽

K Hayden ◽

D Strawn ◽

E Wadman ◽

...

Keyword(s):

Gene Expression ◽

Ulcerative Colitis ◽

Serum Protein ◽

Expression Analysis ◽

Gene Expression Analysis ◽

Molecular Response ◽

Phase 3 ◽

Severe Ulcerative Colitis ◽

Induction Study

Download Full-text

767 Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials

Gastroenterology ◽

10.1016/s0016-5085(16)30622-9 ◽

2016 ◽

Vol 150 (4) ◽

pp. S157 ◽

Author(s):

William Sandborn ◽

Bruce E. Sands ◽

Geert R. D'Haens ◽

Severine Vermeire ◽

Stefan Schreiber ◽

...

Keyword(s):

Ulcerative Colitis ◽

Randomized Controlled Trials ◽

Induction Therapy ◽

Controlled Trials ◽

Efficacy And Safety ◽

Phase 3 ◽

Two Phase ◽

Severe Ulcerative Colitis ◽

Randomized Controlled

Download Full-text

DOP071. Tofacitinib plasma concentration monitoring is not needed for optimisation of induction therapy in moderate-to-severe ulcerative colitis: results of pooled exposure-response analyses of Phase 3 induction studies

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjw019.100 ◽

2016 ◽

Vol 10 (suppl 1) ◽

pp. S73-S74 ◽

Keyword(s):

Ulcerative Colitis ◽

Plasma Concentration ◽

Induction Therapy ◽

Phase 3 ◽

Severe Ulcerative Colitis ◽

Exposure Response

Download Full-text